State Bank of India Eyes $1 Billion for Sun Pharma's $12 Billion Organon Deal
Updated
Updated · Bloomberg · Jun 9
State Bank of India Eyes $1 Billion for Sun Pharma's $12 Billion Organon Deal
2 articles · Updated · Bloomberg · Jun 9
Summary
SBI is set to commit as much as $1 billion to help finance Sun Pharmaceutical Industries' $12 billion overseas acquisition of Organon, people familiar with the matter said.
The proposed funding would place India's largest bank by assets alongside a group of global lenders backing the transaction.
Board approval is still pending, leaving the planned commitment subject to internal signoff before the financing package is finalized.